SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Apr-21 7:03 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Apr-21 | Payment of Exercise | 46 | $24.28 | $1,116.88 | (< 1%) 27.39K to 27.34K | 0% |
02-Mar-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Feb-21 | Payment of Exercise | 357 | $21.66 | $7,732.62 | (1%) 27.74K to 27.39K | (< 1%) |
26-Jan-21 7:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 22-Jan-21 | Grant | 12,600 | -- | -- | 83% 15.14K to 27.74K | |
05-Jan-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-21 | Payment of Exercise | 54 | $24.70 | $1,333.80 | (< 1%) 15.2K to 15.14K | (26%) |
05-Jan-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-20 | Payment of Exercise | 779 | $24.70 | $19,241.30 | (5%) 15.98K to 15.2K | (26%) |
30-Nov-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-20 | Payment of Exercise | 357 | $37.27 | $13,305.40 | (2%) 16.33K to 15.98K | 28% |
05-Oct-20 7:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Oct-20 | Payment of Exercise | 46 | $42.08 | $1,935.68 | (< 1%) 16.38K to 16.33K | 36% |
31-Aug-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Aug-20 | Payment of Exercise | 357 | $48.81 | $17,425.20 | (2%) 16.74K to 16.38K | 45% |
06-Jul-20 7:03 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jul-20 | Payment of Exercise | 46 | $46.52 | $2,139.92 | (< 1%) 16.78K to 16.74K | 42% |
29-May-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-May-20 | Payment of Exercise | 357 | $74.43 | $26,571.50 | (2%) 17.14K to 16.78K | 64% |
29-Apr-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Apr-20 | Market Sale (Planned) | 181 | $85.95 | $15,556.90 | (1%) 17.32K to 17.14K | 69% |
03-Apr-20 7:08 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Apr-20 | Payment of Exercise | 46 | $58.40 | $2,686.40 | (< 1%) 17.37K to 17.32K | 54% |
28-Feb-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Feb-20 | Payment of Exercise | 357 | $85.39 | $30,484.20 | (2%) 17.84K to 17.48K | 69% |
28-Feb-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Feb-20 | Market Sale (Planned) | 113 | $87.62 | $9,901.06 | (< 1%) 17.48K to 17.37K | 69% |
27-Jan-20 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-20 | Market Sale (Planned) | 723 | $94.04 | $67,990.90 | (4%) 18.56K to 17.84K | 72% |
27-Jan-20 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 23-Jan-20 | Grant | 4,800 | -- | -- | 35% 13.76K to 18.56K | |
03-Jan-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-20 | Payment of Exercise | 54 | $123.92 | $6,691.68 | (< 1%) 13.81K to 13.76K | 78% |
03-Jan-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-19 | Payment of Exercise | 364 | $123.92 | $45,106.90 | (3%) 14.18K to 13.81K | 78% |
30-Dec-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Dec-19 | Option Exercise | 470 | $59.08 | $27,765.90 | 3% 15.29K to 15.76K | |
30-Dec-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Dec-19 | Market Option Sale (Planned) | 470 | $123.24 | $57,922.80 | (3%) 15.76K to 15.29K | 78% |
30-Dec-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Dec-19 | Market Sale (Planned) | 1,111 | $123.24 | $136,920.00 | (7%) 15.29K to 14.18K | 78% |
02-Dec-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-19 | Payment of Exercise | 357 | $109.16 | $38,970.10 | (2%) 16.69K to 16.33K | 75% |
02-Dec-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-19 | Option Exercise | 927 | $59.10 | $54,784.50 | 6% 15.76K to 16.69K | |
02-Dec-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-19 | Market Option Sale (Planned) | 927 | $101.65 | $94,229.60 | (6%) 16.33K to 15.4K | 74% |
02-Dec-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-19 | Market Sale (Planned) | 113 | $101.65 | $11,486.50 | (< 1%) 15.4K to 15.29K | 74% |
27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Nov-19 | Option Exercise | 4,373 | $59.11 | $258,491.00 | 28% 15.76K to 20.13K | |
27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Nov-19 | Market Option Sale (Planned) | 4,373 | $100.00 | $437,300.00 | (22%) 20.13K to 15.76K | 73% |
27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-Nov-19 | Option Exercise | 1,855 | $59.10 | $109,628.00 | 12% 15.76K to 17.61K | |
27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-Nov-19 | Market Option Sale (Planned) | 1,855 | $100.00 | $185,500.00 | (11%) 17.61K to 15.76K | 73% |
19-Nov-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 19-Nov-19 | Market Sale (Planned) | 1,550 | $85.00 | $131,750.00 | (9%) 17.31K to 15.76K | 68% |
15-Nov-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 13-Nov-19 | Market Sale (Planned) | 946 | $85.00 | $80,410.00 | (5%) 18.25K to 17.31K | 68% |
03-Oct-19 7:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Oct-19 | Payment of Exercise | 46 | $65.87 | $3,030.02 | (< 1%) 18.3K to 18.25K | 59% |
29-Aug-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Aug-19 | Payment of Exercise | 357 | $60.50 | $21,598.50 | (2%) 18.66K to 18.3K | 56% |
03-Jul-19 5:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jul-19 | Payment of Exercise | 46 | $79.17 | $3,641.82 | (< 1%) 18.7K to 18.66K | 66% |
29-May-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-May-19 | Payment of Exercise | 357 | $87.83 | $31,355.30 | (2%) 19.06K to 18.7K | 70% |
03-Apr-19 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Apr-19 | Payment of Exercise | 46 | $111.50 | $5,129.00 | (< 1%) 19.11K to 19.06K | 76% |
01-Mar-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Mar-19 | Market Sale (Planned) | 333 | $103.16 | $34,352.30 | (2%) 19.44K to 19.11K | 74% |
01-Mar-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Feb-19 | Payment of Exercise | 364 | $92.76 | $33,764.60 | (2%) 19.8K to 19.44K | 71% |
18-Jan-19 7:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 16-Jan-19 | Grant | 4,200 | -- | -- | 27% 15.6K to 19.8K | |
03-Jan-19 7:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-19 | Payment of Exercise | 215 | $100.79 | $21,669.80 | (1%) 15.82K to 15.6K | 73% |
29-Nov-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 29-Nov-18 | Market Sale (Planned) | 1,343 | $113.78 | $152,807.00 | (8%) 17.16K to 15.82K | 76% |
29-Nov-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-18 | Payment of Exercise | 1,438 | $108.66 | $156,253.00 | (8%) 18.6K to 17.16K | 75% |
22-Feb-18 9:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 05-Feb-18 | Grant | 2,100 | -- | -- | 13% 16.5K to 18.6K | |
11-Dec-17 9:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Nov-17 | Grant | 16,500 | -- | -- | 100% 0 to 16.5K | |
14-Apr-15 3:52 PM View: | Fate Therapeutics Inc (FATE) | 13-Apr-15 | Option Exercise | 25,000 | $1.37 | $34,250.00 | 460% 5.43K to 30.43K | |
07-Jan-15 5:15 PM View: | Fate Therapeutics Inc (FATE) | 05-Jan-15 | Grant | 5,429 | -- | -- | 100% 0 to 5.43K | |
03-Apr-14 12:55 PM View: | Fate Therapeutics Inc (FATE) | 02-Apr-14 | Option Exercise | 2,262 | $1.37 | $3,098.94 | 100% 0 to 2.26K | |
03-Apr-14 12:55 PM View: | Fate Therapeutics Inc (FATE) | 02-Apr-14 | Market Option Sale (Planned) | 2,262 | $9.02 | $20,395.10 | (100%) 2.26K to 0 | (994%) |
03-Apr-14 12:55 PM View: | Fate Therapeutics Inc (FATE) | 01-Apr-14 | Option Exercise | 7,738 | $1.37 | $10,601.10 | 100% 0 to 7.74K | |
03-Apr-14 12:55 PM View: | Fate Therapeutics Inc (FATE) | 01-Apr-14 | Market Option Sale (Planned) | 7,738 | $9.02 | $69,789.00 | (100%) 7.74K to 0 | (994%) |